Dopamine Agent

DRUG2 trials

Sponsors

I.R.C.C.S. Fondazione Santa Lucia, Chonnam National University Hospital

Conditions

Cardiogenic ShockParkinson's Disease

Phase 4

Dopaminergic Modulation of Declarative Memory

CompletedNCT03151460

I.R.C.C.S. Fondazione Santa LuciaParkinson's Disease

Start: 2014-09-30End: 2016-04-30Updated: 2017-05-12

Unknown Phase

Assessing Catecholamine Treatment Initiation Options: Norepinephrine vs Dopamine for Cardiogenic Shock

Not yet recruitingNCT07562932

Chonnam National University HospitalCardiogenic Shock

Start: 2026-05-31End: 2032-05-31Target: 512Updated: 2026-05-01